Genes & Development · 2020 · 12 citations · 33 references
Life SciencesGeneticsMolecular BiologyCell SignalingGene ExpressionMetastasisHormone ReceptorsHormone SignalingMammary Gland DevelopmentMetastatic Breast CancerNuclear Receptor SignalingSteroid Hormone SignalingEstrogen Receptor GeneticsEstrogen Receptor SignalingEstrogen ReceptorsImmune-competent Tissue ModelsMammary GlandsMetastatic Breast Cancer BiologyMurine ModelsTransgenic Mouse Models
Mutations in the estrogen receptor α (ERα) occur in endocrine-resistant metastatic breast cancer. However, a major gap persists with the lack of genetically tractable immune competent mouse models to study disease. Hence, we developed a Cre-inducible murine model expressing a point-activated ESR1 Y541S (ESR1 Y537S in humans) driven by its endogenous promoter. Germline expression of mutant ESR1 Y541S reveals dramatic developmental defects in the reproductive organs, mammary glands, and bones of the mice. These observations provide critical insights into the tissue-specific roles of ERα during development and highlights the potential use of our model in further developmental and cancer studies.
33
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Trude Helen Flo, Kelly D. Smith, Shintaro Sato et al. · Nature · 2004 · 1.9K citations
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Sarah L. Anzick, Juha Kononen, Robert L. Walker et al. · Science · 1997 · 1.7K citations
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy, Yang Shen, Helen Won et al. · Nature Genetics · 2013 · 1.3K citations · Full text
The versatile functions of Sox9 in development, stem cells, and human diseases
Alice Jo, Sahitya K. Denduluri, Bosi Zhang et al. · Genes & Diseases · 2014 · 376 citations · Full text
Activating <i>ESR1</i> Mutations Differentially Affect the Efficacy of ER Antagonists
Weiyi Toy, Hazel M. Weir, Pedram Razavi et al. · Cancer Discovery · 2016 · 370 citations · Full text
Medicine, Endocrinology, Oncology +17